Distribution of Eli Lilly COVID-19 therapy paused in 8 states over variant concerns
(NEW YORK) -- Federal health authorities have paused distribution of Eli Lilly's monoclonal antibody cocktail in eight states over COVID-19 variant efficacy concerns.
The COVID-19 treatment will halt distribution in Arizona, California, Florida, Illinois, Indiana, Massachusetts, Oregon and Washington "until further notice" due to variants'... Read More.
